Acurx Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Acurx Pharmaceuticals, Inc. (ACXP) had Shares Outstanding (Cover Page) of 5.27 million shares as of 2026-08-13, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-13: Entity Common Stock, Shares Outstanding 5.27M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 4.30M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 2.86M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 2.09M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 5.27M shares 10-Q · filed 2026-08-13 |
| 2026-05-11 | 4.30M shares 10-Q · filed 2026-05-11 |
| 2026-03-12 | 2.86M shares 10-K · filed 2026-03-12 |
| 2025-11-11 | 2.09M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 1.58M shares 10-Q · filed 2025-08-11 |
| 2025-05-12 | 23.48M shares 10-Q · filed 2025-05-12 |
| 2025-03-17 | 22.04M shares 10-K · filed 2025-03-17 |
| 2024-11-12 | 16.89M shares 10-Q · filed 2024-11-12 |
| 2024-08-08 | 16.25M shares 10-Q · filed 2024-08-08 |
| 2024-05-14 | 15.84M shares 10-Q · filed 2024-05-14 |
| 2024-03-15 | 15.76M shares 10-K · filed 2024-03-15 |
| 2023-11-13 | 13.77M shares 10-Q · filed 2023-11-13 |
| 2023-08-11 | 13.01M shares 10-Q · filed 2023-08-11 |
| 2023-05-12 | 11.67M shares 10-Q · filed 2023-05-12 |
| 2023-03-15 | 11.64M shares 10-K · filed 2023-03-15 |
| 2022-11-10 | 11.59M shares 10-Q · filed 2022-11-10 |
| 2022-08-12 | 11.42M shares 10-Q · filed 2022-08-12 |
| 2022-05-09 | 10.26M shares 10-Q · filed 2022-05-10 |
| 2022-03-15 | 10.23M shares 10-K · filed 2022-03-16 |
| 2021-11-11 | 10.22M shares 10-Q · filed 2021-11-12 |
| 2021-08-13 | 10.12M shares 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |